All Stories

  1. Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review
  2. Review of Pulmonary Embolism
  3. VTE risk scores in guidelines in nonsurgical hospitalized patients with suspected VTE
  4. Sequential Nadroparin and Rivaroxaban in Treatment of Pulmonary Embolism
  5. Diagnostic Strategy Using an Elevated Age-Adjusted D-Dimer Threshold and Thromboembolic Events
  6. A Pulmonary Embolism Diagnostic Strategy in Patients Hospitalized for COPD Exacerbation
  7. Optimal risk assessment score of venous thromboembolism for patients with lung Cancer
  8. Clinical Implications of LTA 4 H Genetic Polymorphism in Patients with COPD
  9. Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
  10. Depletion of PPARγ SUMOylation exaggerates intermittent hypoxia-induced cognitive ecline
  11. Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD
  12. Current Status of the Treatment of Cancer-associated Venous Thromboembolism
  13. An algorithm most appropriate for the prediction of pulmonary embolism in AECOPD
  14. The association between pulmonary embolism and genomic alterations in NSCLC
  15. The role of a biomarker panel in BALF in patients with pulmonary nodules less than 8 mm
  16. Diagnosis of Pulmonary Embolism with d-Dimer Testing
  17. Update on Clinical Aspects of COPD
  18. Coagulation factor IV is an indicator of PE in patients with primary lung cancer
  19. Comparison among different presentations of venous thromboembolism because of lung cancer
  20. A modified risk assessment approach for PAH
  21. The influence of anemia on one-year exacerbation rate of patients with COPD-PH
  22. The influence of compliance to LTOT in the development of PH in patients with COPD with hypoxemia
  23. The relationship between tumor markers and pulmonary embolism in lung cancer
  24. Can we predict the prognosis of COPD with a routine blood test?
  25. A 12 -month follow-up study on the preventive effect of lansuoprazole on AECOPD